Harvard Apparatus Regenerative Technology, Inc. financial data

Symbol
HRGN on OTC
Industry
Surgical & Medical Instruments & Apparatus
Location
84 October Hill Road, Suite 11, Holliston, MA
State of incorporation
DE
Fiscal year end
December 31
Former names
Biostage, Inc. (to 7/10/2023)
Latest financial report
10-K - Q4 2024 - Mar 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 130 % -38.6%
Quick Ratio 4.57 %
Debt-to-equity 75.6 %
Return On Equity -445 % +11.7%
Return On Assets -223 % -2.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 15.9M shares +14.1%
Common Stock, Shares, Outstanding 15.9M shares +14.1%
Entity Public Float 28.3M USD -16.3%
Common Stock, Value, Issued 159K USD +14.4%
Weighted Average Number of Shares Outstanding, Basic 14.8M shares +9.91%
Weighted Average Number of Shares Outstanding, Diluted 15M shares +8.18%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 430K USD
Research and Development Expense 2.31M USD -24.6%
Selling and Marketing Expense 554K USD
General and Administrative Expense 5.02M USD -12.1%
Operating Income (Loss) -7.73M USD +14.1%
Nonoperating Income (Expense) 45K USD -43.8%
Net Income (Loss) Attributable to Parent -7.73M USD +13.6%
Earnings Per Share, Basic -0.52 USD/shares +22.4%
Earnings Per Share, Diluted -0.57 USD/shares +16.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.49M USD +475%
Cash, Cash Equivalents, and Short-term Investments 3.6M USD +140%
Accounts Receivable, after Allowance for Credit Loss, Current 231K USD +5675%
Inventory, Net 80K USD +60%
Assets, Current 3.23M USD +313%
Property, Plant and Equipment, Net 11K USD -56%
Operating Lease, Right-of-Use Asset 293K USD +510%
Other Assets, Noncurrent 62K USD -64.2%
Assets 4.44M USD +69.9%
Accounts Payable, Current 452K USD +1.57%
Employee-related Liabilities, Current 70K USD -11.4%
Liabilities, Current 1.02M USD +5.48%
Operating Lease, Liability, Noncurrent 199K USD
Liabilities 1.22M USD +26%
Accumulated Other Comprehensive Income (Loss), Net of Tax -6K USD
Retained Earnings (Accumulated Deficit) -99.7M USD -8.41%
Stockholders' Equity Attributable to Parent 3.22M USD +95.7%
Liabilities and Equity 4.44M USD +69.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -960K USD +5.23%
Net Cash Provided by (Used in) Financing Activities 801K USD -73.7%
Net Cash Provided by (Used in) Investing Activities -9K USD
Common Stock, Shares Authorized 60M shares 0%
Common Stock, Shares, Issued 15.9M shares +14.1%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2.03M USD -20%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 432K USD -65.2%
Deferred Tax Assets, Valuation Allowance 26.8M USD +7.66%
Deferred Tax Assets, Gross 26.9M USD +7.93%
Operating Lease, Liability 294K USD +513%
Depreciation 6K USD -50%
Payments to Acquire Property, Plant, and Equipment 9K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -7.74M USD +13.5%
Lessee, Operating Lease, Liability, to be Paid 352K USD +604%
Property, Plant and Equipment, Gross 1.49M USD 0%
Operating Lease, Liability, Current 95K USD +97.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 133K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 129K USD +158%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure -6.82%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 58K USD +2800%
Lessee, Operating Lease, Liability, to be Paid, Year Three 90K USD
Deferred Tax Assets, Operating Loss Carryforwards 20.1K USD +6.7%
Preferred Stock, Shares Authorized 2M shares
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 27K USD -10%
Additional Paid in Capital 103M USD +9.94%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 80K USD +515%
Share-based Payment Arrangement, Expense 562K USD +5.05%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares